CONCOMITANT SPARSENTAN AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2is) IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN) IN THE PROTECT OPEN-LABEL EXTENSION (OLE)

https://storage.unitedwebnetwork.com/files/1099/438357534c28d951ab3d87fdef045646.pdf
CONCOMITANT SPARSENTAN AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2is) IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN) IN THE PROTECT OPEN-LABEL EXTENSION (OLE)
Radko
Komers
Laura Kooienga lkooienga@cokidneycare.com Colorado Kidney Care Research Division Denver
Robert Malecki robert.malecki@aol.pl Międzyleski Specialist Hospital Department of Nephrology Warsaw
Alex Mercer alex.mercer@travere.com JAMCO Pharma Consulting N/A Stockholm
Nuhira Ahmed Masthan Ahmed Nuhira.Masthan@travere.com Travere Therapeutics, Inc. Biostatistics San Diego
Priscila Preciado Priscila.preciado@travere.com Travere Therapeutics, Inc. Clinical Development, Nephrology San Diego
 
 
 
 
 
 
 
 
 
 
E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos